Postmenopausal estrogen replacement therapy and the risk of alzheimer's disease: A population-based case-control study

American Journal of Epidemiology

Volumn 140, Issue 3, 1994, Pages 262-267

  Brenner, Daniel E ^a,b   Kukull, Walter A ^a   Stergachis, Andy ^a,c   Van Belle, Gerald ^a   Bowen, James D ^c   Mccormick, Wayne C ^c   Ten, Linda ^c   Larson, Eric B ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CIBA GEIGY LTD   (Switzerland)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Dementia; Estrogen replacement therapy; Senile; Sex factors

Indexed keywords

CONJUGATED ESTROGEN; DIENESTROL; DIETHYLSTILBESTROL; ESTROGEN; ETHINYLESTRADIOL;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; REGRESSION ANALYSIS; RISK FACTOR; SENILE DEMENTIA; TABLET;

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; AGED; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMAN; LOGISTIC MODELS; ODDS RATIO; RISK FACTORS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028142221     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a117245     Document Type: Article

References (24)

1. Jonn AF. The epidemiology of Alzheimer’s disease and related disorders. London, England: Chapman and Hall, 1990.
2. Rocca WA, Hofman A, Brayne C, et al. Frequency and distribution of Alzheimer’s disease in Europe: a collaborative study of 1980-1990 prevalence findings. Ann Neurol 1991;30 381-390.
3. Luine VN. Estradiol increases choline acetyl- transferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 1985;89:484-490.
4. Toran-Allerand CD, Miranda RC, Bentham WDL, et al. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sa U S A 1992;89:4668-4672.
5. Fillit HM, Ashly D, Weinreb H, et al. Estrogen levels in postmenopausal women with senile de- mentia-Alzheimer’s type (SDAT) are significantly lower than matched controls Soc Neurosci Abstr 1986;12:945.
6. Fillit H, Weinreb H, Cholst I, et al. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer’s type. Psychoneuroendocrinology 1986;11:337-345.
7. Honjo H, Ogino Y, Naitoh K, et al. In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer’s type). J Steroid Biochem 1989;34:511-515.
8. Stergachis A. Group Health Cooperative of Puget Sound. In. Storm BL, ed Pharmacoepidemiology New York, NY: Churchill Livingstone, Inc., 1989:149-160.
9. Larson EB, Kukull WA, Teri L, et al. University of Washington Alzheimer’s Disease Patient Registry (ADPR): 1987-1988. Aging 1990;2:404-408.
10. Brenner DE, Kukull WA, Van Belle G, et al Relationship between cigarette smoking and Alzheimer’s disease in a population-based case- control study. Neurology 1993, 43:293-300.
11. American Psychiatric Association. Diagnostic and statistical manual of mental disorders 3rd ed. revised (DMS-III-R). Washington, DC: American Psychiatric Association, 1987.
12. Mckhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939-944.
13. Kukull WA, Hinds TR, Schellenberg GD, et al. Increased platelet membrane fluidity as a diagnostic marker for Alzheimer’s disease: a test in population-based cases and controls. Neurology 1992;42:607-614.
14. Folstein MF, Folstein SE, McHugh PR. Minimental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
15. Coblentz JM, Mattis S, Zingesser LH, et al. Presenile dementia: clinical aspects and evaluation of cerebrospinal fluid dynamics. Arch Neurol 1973;29.299-308.
16. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile changes in gray matter of elderly subjects. Br J Psychiatry 1968;114:797-811.
17. Rothman KJ. Modem epidemiology. Boston, MA: Little, Brown and Company, 1986.
18. Breslow NE, Day NE. Statistical methods in cancer research. Vol. 1. The analysis of case-control studies. Lyon, France: International Agency for Research on Cancer, 1980 247-279. (LARC scientific publication no. 32).
19. Statistics and Epidemiologic Research Corporation. EGRET statistical software. Seattle, WA: Statistics and Epidemiology Research Corporation, 1988.
20. SAS Institute, Inc. SAS/STAT user’s guide, version 6, fourth ed. Vol. 2. Cary, NC: SAS Institute, 1989:1071-1126.
21. Hosmer DW, Lemeshow S. Applied logistic regression. New York, NY: John Wiley amp; Sons, Inc., 1989 82-134.
22. Jick H, Watkins RN, Hunter JR, et al. Replacement estrogens and endometrial cancer. N Engl J Med 1979;300:218-222.
23. Graves AB, White E, Koepsell TD, et al. A case- control study of Alzheimer’s disease. Ann Neurol 1990;28:766-774.
24. Barrett-Connor E, Kritz-Silverstein D Estrogen replacement therapy and cognitive function in older women. JAMA 1993;269:2637-2641.